Format

Send to:

Choose Destination
See comment in PubMed Commons below
Genome Med. 2010 Mar 30;2(3):22. doi: 10.1186/gm143.

Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders.

Author information

  • 1Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE 68198, USA. gpendyala@unmc.edu.

Abstract

Diagnosing neurodegenerative diseases, monitoring their progression and assessing responses to treatments will all be aided by the identification of molecular markers of different stages of pathology. Protein biomarkers for HIV-associated neurocognitive disorders that have been discovered using proteomics include complement C3, soluble superoxide dismutase and a prostaglandin synthase. Metabolomics has not yet been widely used for biomarker discovery, but early work shows that it has great potential.

PMID:
20353544
[PubMed]
PMCID:
PMC2873800
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk